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Background/aim: Ankaferd blood stopper (ABS) is a mixture of certain ratios of 5 different plant roots (Thymus vulgaris, Glycyrrhiza
glabra, Vitis vinifera, Alpinia officinarum, and Urtica dioica). The aim of this study is to evaluate the histopathological effects of ABS on
articular cartilage in vitro.
Materials and methods: Twenty-one albino Sprague Dawley rats were randomly allocated to 3 groups: 0.1 mL of saline was injected in
the first group, 0.1 mL of ABS was injected in the second group, and 0.1 mL of blood and 0.1 mL of ABS were injected in the third group.
One month later all rats were sacrificed. Specimens were obtained for histopathological evaluation.
Results: Significant results were detected in the groups with respect to International Cartilage Repair Society and synovial proliferation
scores (P < 0.05 and P < 0.01). According to inflammatory cell infiltration and fibrin formation scores, there was no significant difference
between group 1 and group 2 (P < 0.01), although there was significant difference between group 3 and the other groups (P > 0.05).
Conclusion: ABS and hemarthrosis had toxic effects on knee cartilage. The side effects were increased with the combination of
hemarthrosis and ABS. As a result, ABS had unexpected effects on experimental hemarthrosis.
Key words: Hemarthrosis, Ankaferd, cartilage

1. Introduction
In intraarticular bleeding in patients with trauma, specific
damage is caused that is associated with inflammatory
cell infiltration and the fibrin formation effects of the
accumulation of blood products (1–3).
Ankaferd blood stopper (ABS) is a compound
obtained from the mixture of certain ratios of 5 different
plant roots (Thymus vulgaris, Glycyrrhiza glabra, Vitis
vinifera, Alpinia officinarum, and Urtica dioica) (1). The
properties of ABS as a powerful hemostatic agent, which
prevents peritoneal adhesions and has positive effects
in the early stage of bone healing, have been reported in
several studies (2,3). Various clinical studies have shown
the use of ABS as an effective hemostatic agent in ear, nose,
throat, and dentistry practice, and in the gastrointestinal
and cardiovascular systems (4,5). Its antihemorrhagic
properties have been shown by several authors in in vivo
and in vitro studies (4,5). The clotting effect of proteins
in the blood as a result of the interaction established with
fibrinogen is demonstrated with the aggregation of red
* Correspondence: dgulabi@yahoo.com
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cells (6–8). In addition, various studies have shown ABS
to have antiinflammatory and antioxidant properties (3,6).
Traumatic hemarthrosis is a frequently encountered
orthopedic problem. Recurrent hemarthrosis has an
adverse effect on the chondral side of the joint. This
adverse effect is due to the blood and blood products in the
joint (9,10). The application of hyaluronic acid, impaction
ultrasound, low-dose laser therapy, and IL-4 and IL-10
administered together has been shown to reduce joint
degeneration in joints with hemarthrosis in in vitro studies
(9–11). The effect on joint cartilage of ABS intraarticular
injection used for a range of hemorrhages is not known as
of yet (12).
The purpose of the present study was to examine
the effect of ABS on the cartilage of the joint. We aimed
to research the suitability of ABS for use in patients
with hemarthrosis by performing a histopathological
examination of the changes in the intraarticular structures
following intraarticular injection of ABS.
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2. Materials and methods
2.1. Study design
Approval for the study was granted by the Animal
Research Committee of İstanbul University. The study was
conducted at the Experimental Research Center (DETAM,
confirmation no.: 2012/43). The histological examination
was performed at the İstanbul University Oncology
Institute Pathology Laboratory. A total of 21 healthy male
albino Sprague Dawley rats, weighing 250–300 g, were
included in the study. The rats were randomly allocated to
3 groups; isotonic serum was administered to group 1 (n
= 7), ABS only to group 2 (n = 7), and blood and ABS to
group 3 (n = 7).
2.2. Experimental study
At 30 min preoperatively, cefazolin sodium 20 mg/kg was
administered intramuscularly as antibiotic prophylaxis,
and an additional dose was given 8 h postoperatively to
terminate the antibiotic prophylaxis procedure. General
anesthesia was applied to all the subjects with a peritoneal
injection of a mixture of 5 mg/kg xylazine hydrochloride
(Rompun; Bayer Healthcare, Leverkusen, Germany)
and 6 mg/kg ketamine HCL (Ketalar, Pfizer, İstanbul,
Turkey). Under aseptic conditions and in order to create
experimental hemarthrosis, 0.1 mL of saline was injected
into the knees of group 1 and 0.1 mL of ABS was injected
into the knees of group 2. In group 3, 0.1 mL of blood was
obtained from the tail of the rats, and this was injected into
their knees together with 0.1 mL of ABS. After awakening,
the animals were allowed free movement in cages with a

12-h light-dark cycle in an air-conditioned environment
at 22 ± 1 °C.
After 1 month, the animals were sacrificed with a highdose phenobarbital injection and the distal femur and
proximal tibia were cut, protecting the knee joint. Samples
were taken from the knees of the sacrificed animals for
histopathological examination of the cartilage status.
After 48 h of fixation in 10% neutral buffered formalin,
the samples were left for 12 h in 10% formic acid in 0.1 M
citrate for decalcification. After the decalcification process,
sections were taken from the length of the femoral condyle.
For histopathological examination of the cartilage, slices
of 5 µm in thickness were prepared in paraffin from the
sections and stained with hematoxylin and eosin (H&E)
and toluidine blue.
A light microscope was used for the evaluations. To
avoid any person-related differences, all variables were
evaluated by a single histopathologist blinded to the
study. In the histopathological evaluation, the synovial
proliferation, inflammation, and amount of fibrin were
scored by the histopathologist on a scale from 0 to 3
(Figures 1–3). These findings were scored according
to the percentage of the area covered: 0%–1% of area
covered = 0, 1%–30% = 1, 30%–60% = 2, >60% = 3.
Changes in the cartilage were scored from 0 to 6 according
to the International Cartilage Repair Society (ICRS)
osteoarthritis and cartilage histopathology classification
system, as it is a straightforward system that has been used
in both experimental and clinical studies (13).

Figure 1. Pathology slice after ABS injection in a knee with
hemarthrosis. The joint surface shows advanced irregularity
and areas of joint cartilage that have lost full layer continuity,
formation of fibrous tissue formed from young mesenchymal
cells in these areas, and synovial cell proliferation in the joint
space and many foreign giant cells (H&E, 200×).

Figure 2. Histopathological examination after ABS application to
the right knee. On 3 joint surfaces, minimal irregularity and small
superficial fissures in the joint cartilage, synovial proliferation,
and scattered macrophages (H&E, 200×).
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Figure 3. Control group: joint surface of normal appearance and
joint cartilage of natural structure (H&E, 200×).

2.3. Statistical analysis
SPSS 15.0 (SPSS Inc., Chicago, IL, USA) was used for
the evaluation of the study data. In addition to the use of
descriptive statistical methods (mean, standard deviation,
median) to evaluate the data, in the comparison of
parameters not showing normal distribution between
the groups, the Kruskal–Wallis test was used, and the
Mann–Whitney U test was used to determine from which
group the difference originated. P < 0.05 was accepted as
statistically significant.
3. Results
The signs of cartilage degeneration, inflammation, and
fibrosis were higher in the hemarthrosis + Ankaferd group.
A statistically significant difference was seen between
the groups in the ICRS stages (P < 0.05). As a result of
the paired comparison applied to determine from which
group the difference originated, the mean cartilage damage
of the hemarthrosis + Ankaferd group was statistically
significantly higher than that of the Ankaferd group and

the control group. The cartilage damage of the Ankaferd
group was determined as statistically significantly higher
than that of the control group (Table).
A statistically significant difference was determined
between the groups in the levels of synovial proliferation
(P < 0.01). As a result of the paired comparison applied
to determine from which group the difference originated,
the level of synovial proliferation of the hemarthrosis +
Ankaferd group was statistically significantly higher than
that of the Ankaferd group and the control group. The
level of synovial proliferation of the Ankaferd group was
determined to be statistically significantly higher than that
of the control group.
A statistically significant difference was determined
between the groups in the levels of fibrin (P < 0.01). As
a result of the paired comparison applied to determine
from which group the difference originated, the level
of fibrin of the hemarthrosis + Ankaferd group was
statistically significantly higher than that of the Ankaferd
group and the control group. No significant difference was
determined between the Ankaferd group and the control
group (P > 0.05).
A statistically significant difference was determined
between the groups in the levels of inflammation (P < 0.01).
As a result of the paired comparison applied to determine
from which group the difference originated, the level of
inflammation of the hemarthrosis + Ankaferd group was
statistically significantly higher than that of the Ankaferd
group and the control group. No significant difference was
determined between the Ankaferd group and the control
group (P > 0.05).
4. Discussion
The most significant finding of this study is that the use of
ABS for hemarthrosis in the knee joint has a negative effect
on the cartilage.
ABS is a traditional herbal essence medication that
has been used for many years in Anatolia. Due to its

Table. Evaluation of cartilage degeneration, synovia, fibrin, and inflammation in the groups.
Ankaferd

Hemarthrosis + Ankaferd

Control

Mean ± SD

Min–max
(median)

Mean ± SD

Min–max
(median)

Mean ± SD

Min–max
(median)

P

Stage of cartilage damage

2 ± 1.41

1–5 (2)

4.14 ± 1.57

2–6 (5)

0±0

0–0 (0)

0.024*

Synovial proliferation

1 ± 0.58

0–2 (1)

2.86 ± 0.38

2–3 (3)

0±0

0–0 (0)

0.001**

Fibrin

0.57 ± 0.53

0–1 (1)

2.43 ± 0.53

2–3 (2)

0±0

0–0 (0)

0.001**

Inflammation

0.14 ± 0.38

0–1 (0)

1.71 ± 0.95

0–3 (2)

0±0

0–0 (0)

0.006**

Kruskal–Wallis test; *: P < 0.05; **: P < 0.01.
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hemostatic effect, ABS is widely used (and approved by
the Turkish Ministry of Health) particularly in dentistry
and in the cardiovascular system, the digestive system,
and stopping bleeding in internal organs (14–16). In an
experimental model, İşler et al. (3) showed the positive
contribution of ABS to the early stages of bone healing. It
was reported that this effect was due to the antioxidant and
antiinflammatory properties of the plant essence.
In a clinical study by Fernandez-Palazzi et al. (9),
successful results were reported for the administration of
rifampicin to 39 hemophilic joints with hemarthrosis. In
the experimental rat model of a study by van Meegeren
et al. (10), cartilage degeneration was seen to decrease
with the intraarticular injection of IL-4 and IL-10. In a
rabbit model used by Ravaanbond et al. (11), impaction
ultrasound and low-dose laser were shown to have
successful results in hemarthrosis treatment.
Iron and cytokines produced by hemarthrosis caused
damage to the synovium and cartilage by stimulating
neoangiogenesis of the hematoma in the joint (17,18). In
an experimental study by Parsons et al., it was determined
that autologous blood injected within the joint resulted
in a reduction of proteoglycan in the cartilage and in
cartilage damage (19). Jansen et al. (18) reported from an
experimental dog model that damage was determined in
the articular cartilage analysis 24–48 h after puncture. This
resulted from the inflammatory reaction, which started in
the synovial tissue of the intraarticular hematoma (18). In
the present study, a statistically significant increase was
observed in the histopathological examination in cartilage
damage, synovial proliferation, fibrin, and inflammation.
This can be considered to result from the inflammatory
process starting from the synovial response triggered
by the hematoma products, as reported by Jansen et al.
(18). Nevertheless, there are opposing views to this, as
some authors have emphasized the antiinflammatory and
antioxidant properties of G. glabra, which is contained in

ABS (8,20–22). Immunochemical analyses are required to
better understand this effect.
A statistically significant difference was observed in the
parameters of the stage of cartilage damage and synovial
proliferation in the histopathological examination of
the knees without hemarthrosis, which received an ABS
injection, compared to the control group. This may have
resulted from the reaction against ABS, which was treated
as a foreign substance by the body. A study by Okumuş
et al. (20), which examined the histopathological changes
in local tissue of rats, reported that there was a significant
inflammatory response in surrounding tissues with 0.1
mL of ABS spray. Similar results were reported by Odabaş
et al. (21). In another experimental model by Cömert et
al. (2) on the effect of ABS on intraperitoneal adhesions,
greater acute and chronic inflammatory changes were
seen in the ABS-applied group compared to the control
group. In an experimental study by Beyazit et al. (22), it
was reported that ABS increased inflammation in Wistar
albino rats. In the present study, increase in inflammation,
stage of cartilage damage, and synovial proliferation were
determined with a dose of 0.1 mL of ABS solution applied
intraarticularly.
The limitations of the present study include the lack
of immunochemical analysis of inflammation precursors
such as IL-1, IL-6, NO, PG-E, and TNF-alpha. In
addition, the follow-up period was short and there was no
observation of results from different doses.
Small sample size and lack of power analysis,
radiological outcome analysis, and toughness analysis
of the cartilage also constitute limitations of the present
study.
In conclusion, the use of ABS in intraarticular
hemarthrosis showed a negative effect on joint cartilage
damage created by blood and blood products. However,
more detailed in vivo and in vitro studies related to the
intraarticular application of ABS would be useful.
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